Effects of omega-3 fatty acids on metabolic syndrome in patients with schizophrenia: a 12-week randomized placebo-controlled trial.

Feikang XuWeixing FanWeiping WangWei TangFuyin YangYi ZhangJun CaiLisheng SongChen Zhang

Published in: Psychopharmacology (2018)

Our findings provide suggestive evidence that omega-3 fatty acids have beneficial effects on TG metabolism in patients with both schizophrenia and MetS that parallel decreased inflammation levels.

Keyphrases

fatty acid
double blind
placebo controlled
metabolic syndrome
bipolar disorder
oxidative stress
clinical trial
phase iii
open label
phase ii
study protocol
insulin resistance
cardiovascular disease
randomized controlled trial
type diabetes